CytoVeris

Farmington, United States

CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.

May 2024

Non-equity Assistance

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are CytoVeris's investors?

CytoVeris's investors include Connecticut Innovations, MedTech Innovator, Cycle Venture Partners, Cycle Ventures.

Where is CytoVeris headquartered?

CytoVeris is headquartered in Farmington, United States.

What does CytoVeris do?

CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.

What stage is CytoVeris at?

CytoVeris is at the Non-equity Assistance stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 29, 2024.

MLA

"CytoVeris — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/cytoveris. Accessed July 2, 2026.

APA

VCBacked. (2024). CytoVeris — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cytoveris

Wikipedia (cite web)

{{cite web |title=CytoVeris — Funding & Investors |url=https://www.vcbacked.co/company/cytoveris |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 29, 2024.